その他の非流動負債（IFRS）、研究開発費 - 社会公共、Proceeds From Sales Of Equity Instruments Measured At Fair Value Through Other Comprehensive Income InvCFIFRSIFRS他1件
- 【期間】
| 年度 | その他の非流動負債（IFRS） | 研究開発費 - 社会公共 | Proceeds From Sales Of Equity Instruments Measured At Fair Value Through Other Comprehensive Income InvCFIFRSIFRS | 前払年金費用 |
|---|
| 2008/03 | - | | - | | - | | 1331億 | |
| 2009/03 | - | | - | | - | | 1235億 | -7.3% |
| 2010/03 | - | | - | | - | | 984億 | -20.3% |
| 2011/03 | - | | - | | - | | 1564億 | +58.9% |
| 2012/03 | - | | - | | - | | 1249億 | -20.1% |
| 2013/03 | - | | - | | - | | 1240億 | -0.7% |
| 2014/03 | - | | - | | - | | 938億 | -24.4% |
| 2015/03 | - | | - | | - | | 486億 | -48.2% |
| 2016/03 | - | | - | | - | | 522億 | +7.6% |
| 2017/03 | - | | - | | - | | 578億 | +10.7% |
| 2018/03 | 294億 | | - | | - | | 588億 | +1.6% |
| 2019/03 | 326億 | +10.8% | - | | 22.9億 | | 670億 | +14% |
| 2020/03 | 343億 | +5.2% | 48億 | | - | | 484億 | -27.8% |
| 2021/03 | 580億 | +69.3% | 107億 | +123.5% | - | | 314億 | -35.1% |
| 2022/03 | 545億 | -6.1% | 111億 | +3.8% | - | | 390億 | +24.1% |
| 2023/03 | 553億 | +1.3% | 99.5億 | -10.7% | - | | 565億 | +44.9% |
| 2024/03 | 468億 | -15.3% | - | | - | | - | |
